Sri Venkaiah Chowdary Nannapaneni, Chairman and Managing Director, NATCO Pharma Limited, a visionary and a humanitarian, believed that no patient should go without medicine or treatment due to economic constraints. His belief inspired him to start NATCO Pharma with a vision of “making speciality medicines accessible to all.” Today, they are market leaders in general oncology, and are known for their path-breaking new discovery of drugs at affordable prices.
The alliance between NATCO Group and L V Prasad Eye Institute first bloomed over two decades ago, when Sri Venkaiah Chowdary Nannapaneni came forward to support LVPEI’s endeavours to eliminate needless blindness. This effort brought out self-reliance in the affected people and communities. In the recent past, they supported LVPEI’s 17th Secondary Care Centre, the ‘NATCO Eye Centre’ at Kothur in Ranga Reddy District.
Each time they came forward to support any of LVPEI’s initiatives, they were stronger than before. More recently, this philanthropic legacy scaled a new high when Mrs Swathi and Mr Rajeev Nannapaneni, Vice Chairman & CEO, NATCO Pharma Limited, made the biggest ever contribution in a single instalment till date. This indeed is a trailblazer in Indian philanthropy for young industrialists.
The latest proceeds have strengthened the efforts of The Child Sight Institute at LVPEI in the areas of children's screening programs, free treatment, and surgeries and providing free spectacles to needy children. Last year, 138,799 children were served through the Institute. Path-breaking research to aid young children, with innovative approaches to cure blindness and visual impairment, is another avenue benefited by this support.
"I am very happy to be associated with LVPEI and I am sure this contribution would help in transforming lives."-Rajeev Nannapaneni